Literature DB >> 25249449

The multifaceted nature of NLRP12.

Sinem Tuncer1, Maria Teresa Fiorillo1, Rosa Sorrentino2.   

Abstract

NLRs are a class of cytoplasmic PRRs with various functions, ranging from pathogen/damage sensing to the modulation of inflammatory signaling and transcriptional control of MHC and related genes. In addition, some NLRs have been implicated in preimplantation and prenatal development. NLRP12 (also known as RNO, PYPAF7, and Monarch-1), a member of the family containing an N-terminal PYD, a NBD, and a C-terminal LRR region, is one of the first described NLR proteins whose role remains controversial. The interest toward NLRP12 has been boosted by its recent involvement in colon cancer, as well as in the protection against some severe infections, such as that induced by Yersinia pestis, the causative agent of plague. As NLRP12 is mainly expressed by the immune cells, and its expression is down-regulated in response to pathogen products and inflammatory cytokines, it has been predicted to play a role as a negative regulator of the inflammatory response. Herein, we present an overview of the NLR family and summarize recent insights on NLRP12 addressing its contribution to inflammatory signaling, host defense, and carcinogenesis.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  NF-κB; Nod-like receptors; cancer; infection; inflammasome

Mesh:

Substances:

Year:  2014        PMID: 25249449     DOI: 10.1189/jlb.3RU0514-265RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  29 in total

Review 1.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

Review 2.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

3.  The innate immune receptor NLRP12 maintains intestinal homeostasis by regulating microbiome diversity.

Authors:  Jenny Moi-Fong Lau; Yvonne Dombrowski
Journal:  Cell Mol Immunol       Date:  2017-07-24       Impact factor: 11.530

4.  NLRP12 negatively modulates inducible nitric oxide synthase (iNOS) expression and tumor necrosis factor-α production in Porphyromonas gingivalis LPS-treated mouse macrophage cell line (RAW264.7).

Authors:  Matsayapan Pudla; Chanya Srisaowakarn; Pongsak Utaisincharoen
Journal:  Inflamm Res       Date:  2019-07-10       Impact factor: 4.575

Review 5.  NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications.

Authors:  Shalini Singh; Sushmita Jha
Journal:  Mol Neurobiol       Date:  2018-03-06       Impact factor: 5.590

6.  NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus.

Authors:  Tatiana N Silveira; Marco Túlio R Gomes; Luciana S Oliveira; Priscila C Campos; Gabriela G Machado; Sergio C Oliveira
Journal:  Eur J Immunol       Date:  2016-12-05       Impact factor: 5.532

Review 7.  NLRP12 in innate immunity and inflammation.

Authors:  Shraddha Tuladhar; Thirumala-Devi Kanneganti
Journal:  Mol Aspects Med       Date:  2020-08-22

Review 8.  Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.

Authors:  Sheryl Coutermarsh-Ott; Kristin Eden; Irving Coy Allen
Journal:  J Gen Virol       Date:  2016-01-13       Impact factor: 3.891

Review 9.  NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.

Authors:  Marjan Gharagozloo; Katsiaryna V Gris; Tara Mahvelati; Abdelaziz Amrani; John R Lukens; Denis Gris
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

10.  The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.

Authors:  Marjan Gharagozloo; Tara M Mahvelati; Emilie Imbeault; Pavel Gris; Echarki Zerif; Diwakar Bobbala; Subburaj Ilangumaran; Abdelaziz Amrani; Denis Gris
Journal:  J Neuroinflammation       Date:  2015-10-31       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.